Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan
NCT ID: NCT00134472
Last Updated: 2012-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
150 participants
INTERVENTIONAL
2002-12-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury
NCT00987688
Hypothermia in Children After Trauma
NCT00222742
Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury
NCT00178711
Targeted Temperature Management After Intracerebral Hemorrhage
NCT01866384
Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever
NCT00890604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapeutic mild hypothermia
Keeping 32 - 34 degree celsius of core temperature at least for 72 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypothermia or anti-hyperthermia must be induced within 6 hours after injury.
Exclusion Criteria
* Thrombocytopenia (platelets \[Plt\] \< 50,000/mm3)
* Pregnancy
* Preexisting medical conditions of severe hepatic dysfunction, heart failure or any other severe organ failure
* Deep drunkenness
15 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Medical Information Network
OTHER
Japan Clinical Research Support Unit(J-CRSU)
UNKNOWN
Yamaguchi University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tsuyoshi Maekawa
Honorary Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tsuyoshi Maekawa, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Yamaguchi University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, Japan
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Fujita Health University Hospital
Toyoake, Aichi-ken, Japan
Chiba University Hospital
Chiba, Chiba, Japan
Chiba Emergency Medical Center
Chiba, Chiba, Japan
Ehime University Hospital
Tōon, Ehime, Japan
Ohta Nishinouchi Hospital
kooriyama, Fukushima, Japan
Gifu University Hospital
Gifu, Gifu, Japan
Sapporo Medical University
Sapporo, Hokkaido, Japan
The Hospital of Hyogo College of Medicine
Nishinomiya, Hyōgo, Japan
Kanazawa University
Kanazawa, Ishikawa-ken, Japan
Iwate Medical University
Morioka, Iwate, Japan
Kagawa University Hospital
Kida, Kagawa-ken, Japan
St. Marianna University, School of Medicine
Kawasaki, Kanagawa, Japan
Kitasato University
Sagamihara, Kanagawa, Japan
Yokohama City Seibu Hospital
Yokohama, Kanagawa, Japan
Aizawa Hospital
Matsumoto, Nagano, Japan
Shinshu University Hospital
Matsumoto, Nagano, Japan
Nara Medical University
Kashihara, Nara, Japan
Oita University Faculty of Medicine
Ōita, Oita Prefecture, Japan
Kawasaki Medical University
Kurashiki, Okayama-ken, Japan
National Hospital Organization Osaka National Hospital
Cyuo, Osaka, Japan
Kansai Medical University
Moriguchi, Osaka, Japan
Osaka Mishima Emergency Medical Center
Takatsuki, Osaka, Japan
Saga Prefectural Hospital Kouseikan
Saga, Saga-ken, Japan
Saitama Medical Center
Kawagoe, Saitama, Japan
Shiga University of Medical Science
Ōtsu, Shiga, Japan
Saiseikai Utsunomiya Hospital
Utsunomiya, Tochigi, Japan
Tokushima University Hospital
Kuramoto, Tokushima, Japan
Nippon Medical School
Bunkyo, Tokyo, Japan
The University of Tokyo Hospital
Bunkyo, Tokyo, Japan
Tokyo Medical University Hachioji Medical Center
Hachiōji, Tokyo, Japan
National Hospital Organization Tokyo Medical Center
Meguro City, Tokyo, Japan
Kyorin University Hospital
Mitaka, Tokyo, Japan
Musashino Red Cross Hospital
Musashino, Tokyo, Japan
Toho University Omori Medical Center
Ōta-ku, Tokyo, Japan
Showa University Hospital
Shinagawa, Tokyo, Japan
Tokyo Medical University
Shinjuku, Tokyo, Japan
Teikyo University Hospital
tabashi City, Tokyo, Japan
Nihon University Itabashi Hospital
tabashi City, Tokyo, Japan
Tama Nagayama Hospital, Nippon Medical School
Tama, Tokyo, Japan
Yamagata University Hospital
Yamagata, Yamagata, Japan
Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital
Ube, Yamaguchi, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H15-HEART-01
Identifier Type: -
Identifier Source: secondary_id
H16-HEART-01
Identifier Type: -
Identifier Source: secondary_id
H14-HEART-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.